賽孚士搭建了國(guó)內(nèi)領(lǐng)先的細(xì)胞系開(kāi)發(fā)、細(xì)胞培養(yǎng)工藝開(kāi)發(fā)、純化工藝開(kāi)發(fā)、制劑工藝開(kāi)發(fā)及商業(yè)化生產(chǎn)等技術(shù)平臺(tái)，擁有豐富的抗體藥物CMC管理及注冊(cè)申報(bào)經(jīng)驗(yàn)，可為客戶(hù)提供符合NMPA、FDA及EMA等標(biāo)準(zhǔn)的高質(zhì)量、一站式、定制化CDMO服務(wù)，服務(wù)內(nèi)容涵蓋從分子設(shè)計(jì)與評(píng)價(jià)、工藝開(kāi)發(fā)、臨床樣品生產(chǎn)、分析與質(zhì)量管理、注冊(cè)申報(bào)到商業(yè)化生產(chǎn)的全鏈條環(huán)節(jié)。賽孚士現(xiàn)已與多家抗體藥領(lǐng)域高新技術(shù)企業(yè)達(dá)成聯(lián)盟合作關(guān)系，同時(shí)積極拓展海外委托生產(chǎn)業(yè)務(wù)。賽孚士致力構(gòu)筑生物醫(yī)藥產(chǎn)業(yè)生態(tài)圈，與生態(tài)伙伴共生共贏，愿成為每一位客戶(hù)值得信賴(lài)的伙伴。

Cellularforce Biopharma has built a domestic leading technology platform for cell line development, cell culture process development, purification process development, preparation process development and commercial production. It has rich experience in antibody drug CMC management and registration application, and can provide customers with high-quality, one-stop, customized CDMO services that meet standards such as NMPA, FDA and EMA. The services cover molecular design and evaluation, process development, manufacturing, clinical sample analysis and quality management, and registration. Cellularforce Biopharma has reached alliance and cooperation with many high-tech enterprises in the field of antibody drugs, and actively expanded overseas entrusted production business. Cellularforce Biopharma is committed to building an ecosystem of bio pharmaceutical industry, symbiosis and win-win with ecological partners, and is willing to become a trusted partner for every customer.